无巩膜瓣悬吊式人工晶状体植入术的临床观察  

Clinical observation on suspensory intraocular lens implantation with no scleral flap

作　　者：汪建[1] 董凤[1] 章晋伟 李先锋[2] 朱益祥[2] 

机构地区：[1]黄石爱尔眼科医院,中国湖北省黄石市435002 [2]中国湖北省黄冈市第三人民医院眼科,438000

出　　处：《国际眼科杂志》2009年第5期966-967,共2页International Eye Science

摘　　要：目的:评价无巩膜瓣悬吊式人工晶状体植入术的临床疗效。方法:回顾性分析63例63眼悬吊式人工晶状体无巩膜瓣植入术的临床资料。结果:平均随访8.3mo,术后1wk最佳矫正远视力≥0.6者5眼(7.9%),0.4～0.5者23眼(36.5%),0.2～0.3者19眼(30.2%),0.05～0.1者10眼(15.9%),≤0.05者6眼(9.5%)。结论:对于矫正无足够后囊膜支持的无晶状体眼的屈光状态,提高患者视力,无巩膜瓣悬吊式人工晶状体植入术是一种安全有效的理想选择,临床值得推广。AIM. To assess the clinical effect of suspensory intraocular lens implantation with no scleral flap. METHODS： The clinical data were retrospectively analyzed in 63 eyes of 63 patients, who were treated with suspensory intraocular lens implantation with no scleral flap. RESULTS. Postoperative best correct distant visual acuity （BCDVA） achieved 0.6 or over in 5 eyes （7.9%）, 0.4- 0.5 in23 eyes （36.5%）, 0.2-0.3 in 19 eyes（30.2%）, 0.05-0.1 in 10 eyes（15.9%）, below 0. 05 in 6 eyes （9. 5%） at 8. 3 months of mean follow-up period. CONCLUSION： In order to correct aphakia in eyes of patients without posterior capsular, intraocular lens implantation with no scleral flap is an effective and safe method for clinical work.

关 键 词：无晶状体眼 无巩膜瓣悬吊式人工晶状体植入术 临床观察 

分 类 号：R779.66[医药卫生—眼科]